Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-12-11
2007-12-11
Lukton, David (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S327000, C530S328000, C530S329000, C530S330000, C514S002600, C514S006900, C514S016700, C514S018700, C556S001000, C556S045000
Reexamination Certificate
active
10640755
ABSTRACT:
Metallopeptides are provided for use in treatment of sexual dysfunction in mammals. The metallopeptides are agonists for at least one of melanocortin-3 or melanocortin-4 receptors. The metallopeptides are conformationally fixed on complexation of a metal ion-binding portion thereof with a metal ion. Also provided are metallopeptides that are antagonists for at least one of melanocortin-3 or melanocortin-4 receptors.
REFERENCES:
patent: 5576290 (1996-11-01), Hadley
patent: 5622860 (1997-04-01), Yamada et al.
patent: 5639778 (1997-06-01), Andersson et al.
patent: 5668254 (1997-09-01), Deghenghi
patent: 5674839 (1997-10-01), Hruby et al.
patent: 5693608 (1997-12-01), Bechgaard et al.
patent: 5703220 (1997-12-01), Yamada et al.
patent: 5710265 (1998-01-01), Yamada et al.
patent: 5714576 (1998-02-01), Hruby et al.
patent: 5731408 (1998-03-01), Hadley et al.
patent: 5766877 (1998-06-01), Stark et al.
patent: 5770178 (1998-06-01), Itaya et al.
patent: 5837521 (1998-11-01), Cone et al.
patent: 5891418 (1999-04-01), Sharma
patent: 5908609 (1999-06-01), Lee et al.
patent: 5908825 (1999-06-01), Fasano et al.
patent: 5932779 (1999-08-01), Lee et al.
patent: 5977070 (1999-11-01), Piazza et al.
patent: 5994087 (1999-11-01), Cone et al.
patent: 6027711 (2000-02-01), Sharma
patent: 6048527 (2000-04-01), Granoff et al.
patent: 6051555 (2000-04-01), Hadley
patent: 6054556 (2000-04-01), Huby et al.
patent: 6060589 (2000-05-01), Stark et al.
patent: 6100048 (2000-08-01), Cone et al.
patent: 6117975 (2000-09-01), Yamada et al.
patent: 6126916 (2000-10-01), McBride et al.
patent: 6127381 (2000-10-01), Basu et al.
patent: 6210942 (2001-04-01), Lewis et al.
patent: 6225086 (2001-05-01), Morrow et al.
patent: 6689813 (2004-02-01), Keri et al.
patent: 2001/0009899 (2001-07-01), Keri et al.
patent: 2001/0029259 (2001-10-01), Nargund et al.
patent: 2002/0012948 (2002-01-01), Sharma et al.
patent: WO 98/10068 (1998-03-01), None
patent: WO 98/27113 (1998-06-01), None
patent: WO 98/56914 (1998-12-01), None
patent: WO 99/21571 (1999-05-01), None
patent: WO 99/43709 (1999-09-01), None
patent: WO 99/54358 (1999-10-01), None
patent: WO 99/55679 (1999-11-01), None
patent: WO 99/57148 (1999-11-01), None
patent: WO 99/64002 (1999-12-01), None
patent: WO 00/05263 (2000-02-01), None
patent: WO 00/06777 (2000-02-01), None
patent: WO 00/14115 (2000-03-01), None
patent: WO 00/33658 (2000-06-01), None
patent: WO 00/36136 (2000-06-01), None
patent: WO 00/39147 (2000-07-01), None
patent: WO 00/44898 (2000-08-01), None
patent: WO 00/53148 (2000-09-01), None
patent: WO 00/58361 (2000-10-01), None
patent: WO 00/74679 (2000-12-01), None
patent: WO 01/00224 (2001-01-01), None
patent: WO 01/05401 (2001-01-01), None
patent: WO 01/10842 (2001-02-01), None
patent: WO 01/13112 (2001-02-01), None
patent: WO 01/23392 (2001-04-01), None
patent: WO 01/30808 (2001-05-01), None
patent: WO 01/52880 (2001-07-01), None
patent: WO 01/55106 (2001-08-01), None
patent: WO 01/55107 (2001-08-01), None
patent: WO 01/55109 (2001-08-01), None
patent: WO 01/70337 (2001-09-01), None
patent: WO 01/70708 (2001-09-01), None
patent: WO 01/74844 (2001-10-01), None
patent: WO 01/85930 (2001-11-01), None
patent: WO 01/90140 (2001-11-01), None
patent: WO 01/91752 (2001-12-01), None
Fabris, D. , et al., “Investigation of Zinc Chelation in Zinc-Finger Arrays by Electrospray Mass Spectrometry”,Inorganic Chemistry, vol. 38, (1999),1322-1325.
Giblin, Michael F., et al., “Design and Characterization of ()-melanocortin Peptide Analogs Cyclized through Rhenium and Technetium Metal Coordination”,Proceedings of National Academy Science USA, vol. 95, (Oct. 1998),12814-12818.
Shi, Yi-Qun , et al., “Conformationally Constrained Metallpeptide Template for Melanocortin-1 Receptor”,American Chemical Society, 218th ACS National Meeting, Abstracts of Papers, Part 1, Abstract MEDI 257, (Aug. 22, 1999).
Wessells, Hunter; et al.; “Sythetic Melanotropic Peptide Initiates Erections in Men with Psychogenic Erectile DysfunctionL Double-Bline, Placebo Controlled Crossover Study,” J Urol, vol. 160(2), Aug. 1998: pp. 389-393.
Hruby, Victor; et al.; “Emerging approaches in molecular dsign of receptor-selective peptide ligands: conformation, topographical and dynamic considerations,” J Biochem (1990), vol. 268: pp. 249-262.
“Synthetic Peptides. A Users Guide”; ed. Gregory A. Grant; W.H. Freeman & Co., New York; 1992, pp. 11-24.
Cai Hui-Zhi
Shadiack Annette
Sharma Shubh
Shi Yi-Qun
Yang Wei
Lukton David
Palatin Technologies Inc.
Slusher Stephen A.
LandOfFree
Melanocortin metallopeptides for treatment of sexual... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Melanocortin metallopeptides for treatment of sexual..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanocortin metallopeptides for treatment of sexual... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3896220